{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:05:52Z","timestamp":1768457152801,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP1100036"],"award-info":[{"award-number":["APP1100036"]}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE140100036"],"award-info":[{"award-number":["CE140100036"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jconrel.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T18:43:51Z","timestamp":1546541031000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation"],"prefix":"10.1016","volume":"296","author":[{"given":"Enyuan","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Martinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luojuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Lindfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalle","family":"Sigfridsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Skantze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie L.","family":"Trevaskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-7551","authenticated-orcid":false,"given":"Christopher J.H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.01.002_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0010","doi-asserted-by":"crossref","first-page":"18784","DOI":"10.1073\/pnas.1116152108","article-title":"Impaired lymphatic contraction associated with immunosuppression","volume":"108","author":"Liao","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2006.05.001","article-title":"Immunopathogenesis of acute AIDS virus infection","volume":"18","author":"Picker","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.addr.2011.05.014","article-title":"Role of the lymphatics in cancer metastasis and chemotherapy applications","volume":"63","author":"McAllaster","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour: targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070703","article-title":"Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes","volume":"8","author":"Weitman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cvr\/cvv117","article-title":"Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling","volume":"107","author":"Scallan","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/01926230600867743","article-title":"Normal structure, function, and histology of the spleen","volume":"34","author":"Cesta","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0952-7915(93)90012-H","article-title":"Gut intraepithelial T lymphocytes","volume":"5","author":"Guy-Grand","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0050","first-page":"1154","article-title":"Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer","volume":"37","author":"Saxon","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13152","article-title":"NRROS negatively regulates reactive oxygen species during host defence and autoimmunity","volume":"509","author":"Noubade","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0060","first-page":"142","article-title":"Increased proliferative response of lymphocytes from intestinal lymph during long chain fatty acid absorption","volume":"78","author":"Miura","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0065","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/mp100259a","article-title":"Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?","volume":"7","author":"Trevaskis","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.12.031","article-title":"Targeted delivery of a model immunomodulator to the lymphatic system: Comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies","volume":"177","author":"Han","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0075","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s11095-010-0199-2","article-title":"The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles","volume":"27","author":"Trevaskis","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0080","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/bit.22337","article-title":"A tissue-engineered model of the intestinal lacteal for evaluating lipid transport by lymphatics","volume":"103","author":"Dixon","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0085","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s11095-013-1218-x","article-title":"Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal","volume":"30","author":"Reed","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2012.03.013","article-title":"Liver X receptor biology and pharmacology: new pathways, challenges and opportunities","volume":"33","author":"Jakobsson","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0095","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/14728222.2013.806490","article-title":"Targeting liver X receptors in inflammation","volume":"17","author":"Steffensen","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1172\/JCI42974","article-title":"Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation","volume":"121","author":"Cui","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1751-2980.2011.00554.x","article-title":"Liver X receptors bridge hepatic lipid metabolism and inflammation","volume":"13","author":"Liu","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0115","article-title":"Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in cholesteryl ester transfer protein-expressing species and inhibits atherosclerotic lesion progression in low density lipoprotein receptor knockout mice","volume":"116","author":"Nambi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0120","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1194\/jlr.M900037-JLR200","article-title":"LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse","volume":"50","author":"Quinet","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0091270009335768","article-title":"Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants","volume":"49","author":"Katz","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/la052367t","article-title":"Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations","volume":"22","author":"Lindfors","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0135","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1021\/la700811b","article-title":"Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth","volume":"23","author":"Lindfors","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/jpet.102.045328","article-title":"A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum","volume":"305","author":"Johnson","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0145","first-page":"142","article-title":"Increased proliferative response of lymphocytes from intestinal lymph during long chain fatty acid absorption","volume":"78","author":"Miura","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2019.01.002_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00264","article-title":"IL-2 expression in activated human memory FOXP3+ cells critically depends on the cellular levels of FOXP3 as well as of four transcription factors ofT cell activation","volume":"3","author":"Bendfeldt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00281-005-0206-6","article-title":"The role of mucosal T lymphocytes in regulating intestinal inflammation","volume":"27","author":"Uhlig","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-230X-12-172","article-title":"Murine CD4(+)CD25(\u2212) cells activated in vitro with PMA\/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo","volume":"12","author":"Majowicz","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0165","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(86)90050-5","article-title":"Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT","volume":"33","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","article-title":"Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats","volume":"89","author":"Caliph","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0185","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1007\/s11095-013-1000-0","article-title":"A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport","volume":"30","author":"Trevaskis","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0190","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.24670","article-title":"Constitutive triglyceride turnover into the mesenteric lymph is unable to support efficient lymphatic transport of a biomimetic triglyceride prodrug","volume":"105","author":"Han","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/ajplegacy.1951.166.2.451","article-title":"Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths","volume":"166","author":"Bloom","year":"1951","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0105-2896.2005.00285.x","article-title":"Lymphocyte homing to the gut: attraction, adhesion, and commitment","volume":"206","author":"Salmi","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20090858","article-title":"Dynamic T cell migration program provides resident memory within intestinal epithelium","volume":"207","author":"Masopust","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0210","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1079\/BJN2001455","article-title":"Fatty acids and lymphocyte functions","volume":"87","author":"Calder","year":"2002","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0215","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/S0021-9258(17)35692-2","article-title":"Promotion of human T lymphocyte activation and proliferation by fatty acids in low density and high density lipoproteins","volume":"261","author":"Cuthbert","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.01.002_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15026-z","article-title":"Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation","volume":"7","author":"Zgair","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919300021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919300021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T17:43:58Z","timestamp":1662745438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"alternative-id":["S0168365919300021"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}